• Introduction
• 16 min
  1. Psychopharmacology: structural aspects of the brain

  • Prof. Brian Leonard
• 66 min
  2. The nature of chemical neurotransmission

  • Prof. Brian Leonard
• 28 min
  3. Psychotropic drugs

  • Prof. Brian Leonard
• 26 min
  4. Psychopharmacology of anxiety disorders

  • Prof. Brian Leonard
• 35 min
  5. Psychopharmacology of depression

  • Prof. Brian Leonard
• 48 min
  6. Psychopharmacology of mania and schizophrenia

  • Prof. Brian Leonard
• 45 min
  7. The role of stress and immune system in psychiatric disorders

  • Prof. Brian Leonard
• Introduction to Genetic Investigations of Complex Traits
• 39 min
  8. Genetic association studies, TDT and the candidate gene approach

  • Dr. Jo Knight
• Genetics and Pharmacokinetics of Psychotropic Drugs
• 34 min
  9. Genetics of phase I enzymes

  • Prof. Aiming Yu
• 36 min
  10. Phase II metabolism

  • Prof. Ann Daly
• Genetics and Pharmacodynamics of Psychotropic Drugs
• 25 min
  11. Genetics and psychotropic drugs: present and future clinical applications

  • Dr. Chiara Fabbri
• 25 min
  12. Influence of neurotransmitter receptor variants on interactions with psychotropic drugs

  • Dr. Maria Arranz
• 51 min
  13. Pharmacogenetics of antidepressants

  • Prof. Alessandro Serretti
• Clinical Applications of Psychopharmacogenetics
• 41 min
  14. Of genes and drugs: genetic determinants of adverse drug reactions

  • Dr. Mario Masellis
• 35 min
  15. Cocaine and amphetamine addiction genetics

  • Dr. Gerome Breen
• 29 min
  16. Tailoring psychiatric treatment using genetic information: pharmacogenetic prediction of treatment response

  • Dr. Maria Arranz
• Archived Lectures *These may not cover the latest advances in the field
• 47 min
  17. Genetic, environmental and other design issues relevant for pharmacogenetics studies

  • Dr. Ridha Joober
• 37 min
  18. Genetic determinants of metabolism: clinical applications in psychiatry

  • Prof. Julia Stingl (formerly Kirchheiner)
• 36 min
  19. Rapid methods for the genetic determination of pharmacokinetic status

  • Dr. Paul Debenham
• 47 min
  20. Genetic polymorphisms influencing response to lithium

  • Prof. Alessandro Serretti
• 28 min
  21. Genetic determinants of antipsychotic-induced weight gain

  • Prof. Gavin Reynolds
• 59 min
  22. Pharmacogenetics of tardive dyskinesia: a "movement" towards individualized therapy 1

  • Dr. Vincenzo Basile
• 50 min
  23. Pharmacogenetics of tardive dyskinesia: a "movement" towards individualized therapy 2

  • Dr. Vincenzo Basile
• 37 min
  24. Genetic determinants of agranulocytosis

  • Dr. Michael Dettling
• 52 min
  25. Genetic polymorphisms influencing the response of antidepressants

  • Prof. Alessandro Serretti

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Diagram of GABAergic pathways in brain
3. Anxiety symptoms
4. Anxiety disorders
5. Drugs used to treat anxiety disorders
6. The basic structure of the GABA receptor
7. Different GABA receptor subunits
8. Benzodiazepines increase GABAergic activity
9. Mechanism of benzodiazepine function
10. The complexity of the GABAergic receptor
11. Anxiolytics and the benzodiazepine receptor
12. Noradrenergic pathways in GAD

Topics Covered

• GABAergic pathways in normal brain
• Drugs used in the treatment of anxiety disorders
• Drugs that modulate the GABA receptor
• Anxiolytics and benzodiazepine receptor
• Noradrenergic pathways in generalized anxiety disorder (GAD)

Links

Series:

• Psychopharmacogenetics

Categories:

• Neuroscience
• Pharmaceutical Sciences

Therapeutic Areas:

• Neurology

Talk Citation

Publication History

• Published on October 1, 2007

Financial Disclosures

• Prof. Brian Leonard has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.